L-Selectin was initially identified in 1983 as a lymph node-homing receptor. It is a type I transmembrane glycoprotein that is expressed on leukocytes and implicated in the recruitment of leukocytes to lymph nodes and inflamed tissues. L-Selectin is encoded by the SELL gene on human and mouse chromosome 1 and is also present in mice. T cells, B cells, and neutrophils are the cell types where the L-Selectin function is most understood. Later research revealed that there are additional L-Selectin ligands, including PSGL-1, which binds P- and E-Selectin as well as MAdCAM-1, which is found in the mesenteric lymph node of the gut mucosa.
Fig.1 Crystal structure of L-Selectin lectin/EGF domains. (PDB)
There are just a few small changes in the amino acid residues in the cytoplasmic tail and extracellular cleavage site between the structures of L-Selectin in humans and mice. Due to variations in glycosylation patterns, the molecular weight of L-Selectin ranges from 65 to 100 kDa depending on the type of cell. While L-Selectin attaches to sulphated sialyl-lewis X (sLex) epitopes on proteins including CD34, podocalyxin, and glycosylation-dependent cell adhesion molecule-1, E- and P-Selectins bind sialyl-lewis X (sLex) epitopes on scaffold proteins like PSGL-1 and CD44 (GlyCAM-1). Cells get tethered to the vasculature and begin to roll due to these interactions.
L-Selectin (CD62L) is made up of an intracellular domain (ICD) at the C-terminus, a transmembrane domain (TMD), which crosses the cell membrane, and an extracellular domain (ECD), which includes the C-type lectin domain at the N-terminus, the epidermal growth factor (EGF)-like domain, two short consensus repeat domains, and the cleavage site. L-Selectin is proteolytically shed by A disintegrin and metalloproteinase 17 (ADAM17).
Fig.2 The structure of transmembrane glycoprotein L-Selectin and enzyme ADAM17. (Reed & Ager, 2022)
Even in the absence of P- or E-Selectin, L-Selectin has the ability to regulate leukocyte homing. In order to protect the host from infection, leukocyte trafficking is a critical step that coordinates the immune response. It involves a number of homing molecules and receptors on leukocytes as well as blood arteries. Naive and central memory cells are traditionally guided to lymph nodes by L-Selectin through high endothelial venules (HEVs). According to recent research, L-Selectin is necessary for the homing of activated CD8+ T cells to lungs that are infected with influenza as well as for the lowering of viral load.
When naive T cells with high L-Selectin levels meet an antigen and become activated, they release L-selectin and transform into effector cells with downregulated L-Selectin expression. After the illness has been treated, these cells continue to grow and become memory cells. Although the process is yet unknown, memory cells are either low L-Selectin level or re-express L-Selectin. Acute inflammation, inflammatory bowel disease (IBD), and cancer are also connected to L-Selectin.
Modulating L-Selectin interactions has been done in a variety of ways. One strategy is to directly prevent L-Selectin and its ligands from interacting. Oligosaccharides as ligand analogs and soluble protein ligands are useful tools to block L-Selectin binding. Additionally, approaches that target processes upstream or downstream, including inhibiting the enzymes necessary for the crucial post-translational modifications of L-Selectin ligands, are potentially intriguing.
Fig.3 L-Selectin on T cells. (Ivetic, et al., 2019)
CD BioGlyco has advanced platforms and provides customized solutions according to research needs. if you are interested in our services, please contact us for more information.
References
About Us
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
Contact Us
